FibroGen Inc.
FGEN | NASDAQ
$9.07
-$0.15 (-1.63%)
At close: Jan 12, 2026, 09:30 AM ET
-1.63%
(1Y)Key Statistics
Market Data
Market Cap $36.69M
1D Range
9.02 9.21
52W Range
4.85 21.95
Valuation (TTM)
PE 0.20
PB -4.51
EV/EBITDA 1.45
Valuation (NTM)
Forward PE N/A
Forward PEG 0.01
Price Target $28
Cash Flow
FCF Yield -103.7%
SBC Adj. FCF Yield -114.6%
SBC Impact -10.5%
Margins
Gross Margin 78.4%
Operating Margin -1090.0%
FCF Margin -824.6%
Growth (CAGR)
Revenue 3Y | 5Y -67.2% |
-51.5%
Dil EPS 3Y | 5Y 198.8% |
149.4%
FCF 3Y | 5Y 93.5% |
32.4%
Returns
ROA 181.2%
ROE -2443.6%
ROIC -77.4%
Financial Health
Net Cash
$91.32M
Current Ratio 2.69
Interest Coverage 82.62
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
A detailed description of the company is not yet available.
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$28
Upside
+208.71%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove FGEN